The Journal of Heart and Lung Transplantation
Volume 29, Issue 3 , Pages 286-290, March 2010

Infections in heart transplant recipients in Brazil: The challenge of Chagas' disease

  • Henrique L. Godoy, MD

      Affiliations

    • Division of Cardiology, Department of Medicine, Federal University of São Paulo, São Paulo, Brazil
    • Corresponding Author InformationReprint requests: Henrique L. Godoy, MD, Federal University of São Paulo Cardiology, Botucatu St, 740 10th Flr, 4023—900 São Paulo—SP, Brazil. Telephone: 55-11-55993669. Fax: 55-11-5599369
  • ,
  • Carla M. Guerra, MD, MS

      Affiliations

    • Division of Infectious Disease, Department of Medicine, Federal University of São Paulo, São Paulo, Brazil
  • ,
  • Ruy F. Viegas, MD

      Affiliations

    • Division of Cardiology, Department of Medicine, Federal University of São Paulo, São Paulo, Brazil
  • ,
  • Rosiane Z. Dinis, MD, PhD

      Affiliations

    • Division of Cardiology, Department of Medicine, Federal University of São Paulo, São Paulo, Brazil
  • ,
  • Joao N. Branco, MD, PhD

      Affiliations

    • Department of Surgery, Federal University of São Paulo, São Paulo, Brazil
  • ,
  • Vicente A. Neto, MD, PhD

      Affiliations

    • Medical Investigation Laboratory - Parasitology, Tropical Medicine Institute, University of São Paulo, São Paulo, Brazil
  • ,
  • Dirceu R. Almeida, MD, PhD

      Affiliations

    • Division of Cardiology, Department of Medicine, Federal University of São Paulo, São Paulo, Brazil

published online 28 September 2009.

Background

Despite the high incidence of infections after heart transplantation, there is limited information about its epidemiology in patients from countries where Chagas' disease is endemic.

Methods

We analyzed the occurrence of infections in 126 patients aged older than 18 years who underwent transplantation from 1986 through 2007 at a Brazilian University Hospital and who survived at least 48 hours.

Results

Heart failure diagnoses before transplantation were idiopathic dilated cardiomyopathy (38.6%), Chagas' disease (34.9%), coronary artery disease (19.8%), and others (6.3%). The respiratory tract was the most common site of infections (40.9%), followed by surgical wound site (18.1%). Trypanosoma cruzi reactivations occurred in 38.8% of Chagas' disease patients: 47.0% had myocarditis, 23.5% had skin lesions, and 29.4% had both. New-onset ventricular dysfunction was observed in 47.0%, with complete response after specific treatment, and 41.0% were asymptomatic cases, diagnosed by routine endomyocardial biopsies. No patient died from such events. No differences in survival were found after 5 years of follow-up between recipients with and without Chagas' disease (p = 0.231).

Conclusions

In a heart transplant population from a developing country, infectious complications occurred at a high rate. Tropical illnesses were uncommon, except for the high rate of Chagas' disease reactivations. Despite that, the overall outcome of these patients was similar to that of recipients with other cardiomyopathies.

Keywords: Chagas' disease, Trypanosoma cruzi, immunosuppression, infections, allopurinol

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1053-2498(09)00632-9

doi:10.1016/j.healun.2009.08.006

The Journal of Heart and Lung Transplantation
Volume 29, Issue 3 , Pages 286-290, March 2010